Stephen D. Silberstein, the professor of neurology and director of the Headache Center, explained that "with the FDA's decision to approve Gamma Core for migraines, patients now have access to an effective and safe treatment that can be self-administered to treat acute pain associated with migraines."
PRESTO - Study - Patients - Migraines - Members
The PRESTO study included 243 patients with episodic migraines. Significantly more members of the group who received non-invasive vagal nerve stimulation were pain-free after 30 minutes (12.7%) than those who received a placebo treatment (4.2%; p = 0.01). A higher percentage of the group that received vagus nerve stimulation were pain-free at 60 minutes (21% vs....